Question 1

What are the potential side effects of switching from oral to intravenous SPM 927?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures clinical trial (NCT00151879). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the trial affect my current seizure management plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures clinical trial (NCT00151879). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of monitoring will be done during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures clinical trial (NCT00151879). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures clinical trial (NCT00151879). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens after the trial ends?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures clinical trial (NCT00151879). Contact the study team or your healthcare provider for specific answers.

What this study is about